Breaking News, Promotions & Moves

Pfenex Announces New COO

Dr. Shawn A. Scranton joins the company with two decades of industry experience

Pfenex Inc. announced that Dr. Shawn A. Scranton, will be joining the company as its chief operating officer, effective October 1, 2018. “As our operations have evolved through the advancement of our clinical pipeline and Pfenex is working towards its first NDA submission, we are increasing our focus on the approval and commercialization of our existing pipeline as well as exploration of new pipeline and technology opportunities. I am excited to announce the appointment of Dr. Shawn...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters